<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458511431072</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458511431072</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Pichiecchio</surname><given-names>A</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511431072">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tavazzi</surname><given-names>E</given-names></name>
<xref ref-type="aff" rid="aff2-1352458511431072">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Poloni</surname><given-names>G</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511431072">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ponzio</surname><given-names>M</given-names></name>
<xref ref-type="aff" rid="aff3-1352458511431072">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Palesi</surname><given-names>F</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511431072">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pasin</surname><given-names>M</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511431072">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Piccolo</surname><given-names>L</given-names></name>
<xref ref-type="aff" rid="aff2-1352458511431072">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tosello</surname><given-names>D</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511431072">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Romani</surname><given-names>A</given-names></name>
<xref ref-type="aff" rid="aff2-1352458511431072">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bergamaschi</surname><given-names>R</given-names></name>
<xref ref-type="aff" rid="aff2-1352458511431072">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Piccolo</surname><given-names>G</given-names></name>
<xref ref-type="aff" rid="aff2-1352458511431072">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bastianello</surname><given-names>S</given-names></name>
<xref ref-type="aff" rid="aff4-1352458511431072">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458511431072"><label>1</label>Neuroradiology Department, IRCCS National Neurological Institute IRCCS “C. Mondino”, Pavia, Italy.</aff>
<aff id="aff2-1352458511431072"><label>2</label>Neurology Department, National Neurological Institute IRCCS “C. Mondino”, Pavia, Italy.</aff>
<aff id="aff3-1352458511431072"><label>3</label>Department of Health Sciences, Unit of Medical Statistics and Epidemiology, University of Pavia, Italy.</aff>
<aff id="aff4-1352458511431072"><label>4</label>Neuroradiology Department, IRCCS National Neurological Institute IRCCS “C. Mondino”, University of Pavia, Italy.</aff>
<author-notes>
<corresp id="corresp1-1352458511431072">Dr Anna Pichiecchio, Department of Neuroradiology, Institute of Neurology I.R.C.C.S. “C. Mondino”, Via Mondino 2, 27100 Pavia, Italy. Email: <email>anna.pichiecchio@mondino.it</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>6</issue>
<fpage>817</fpage>
<lpage>824</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>1</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>5</day>
<month>5</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>7</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>10</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>11</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><bold>Background:</bold> Several authors have used advanced magnetic resonance imaging (MRI) techniques to investigate whether patients with neuromyelitis optica (NMO) have occult damage in normal-appearing brain tissue, similarly to multiple sclerosis (MS). To date, the literature contains no data derived from the combined use of several advanced MRI techniques in the same NMO subjects.</p>
<p><bold>Objective:</bold> We set out to determine whether occult damage could be detected in the normal-appearing brain tissue of a small group of patients with NMO using a multiparametric MRI approach.</p>
<p><bold>Methods:</bold> Eight female patients affected by NMO (age range 44–58 years) and seven sex- and age-matched healthy controls were included. The techniques used on a 1.5 T MRI imaging scanner were magnetization transfer imaging, diffusion tensor imaging, tract-based spatial statistics, spectroscopy and voxel-based morphometry in order to analyse normal-appearing white matter and normal-appearing grey matter.</p>
<p><bold>Results:</bold> Structural and metabolic parameters showed no abnormalities in normal-appearing white matter of patients with NMO. Conversely, tract-based spatial statistics demonstrated a selective alteration of the optic pathways and the lateral geniculate nuclei. Diffusion tensor imaging values in the normal-appearing grey matter were found to be significantly different in the patients with NMO versus the healthy controls. Moreover, voxel-based morphometry analysis demonstrated a significant density and volume reduction of the sensorimotor cortex and the visual cortex.</p>
<p><bold>Conclusions:</bold> Our data disclosed occult structural damage in the brain of patients with NMO, predominantly involving regions connected with motor and visual systems. This damage seems to be the direct consequence of transsynaptic degeneration triggered by lesions of the optic nerve and spine.</p>
</abstract>
<kwd-group>
<kwd>Advanced MRI techniques</kwd>
<kwd>DTI</kwd>
<kwd>neuromyelitis optica</kwd>
<kwd>spectroscopy</kwd>
<kwd>VBM</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1352458511431072" sec-type="intro">
<title>Introduction</title>
<p>Devic’s neuromyelitis optica (NMO), which can be mono- or multiphasic<sup><xref ref-type="bibr" rid="bibr1-1352458511431072">1</xref></sup>, is an inflammatory demyelinating disease of the central nervous system consisting of acute severe transverse myelitis and optic neuritis (ON). The updated NMO diagnostic criteria<sup><xref ref-type="bibr" rid="bibr2-1352458511431072">2</xref></sup> contain two major new elements. These are related to the discovery of a specific biomarker for the disease that might have a pathogenetic role, namely anti-aquaporin 4 antibody (Ab antiaqp4),<sup><xref ref-type="bibr" rid="bibr3-1352458511431072">3</xref></sup> and to the possible presence of brain parenchymal abnormalities enabling differentiation of NMO from multiple sclerosis (MS)<sup><xref ref-type="bibr" rid="bibr4-1352458511431072">4</xref>-<xref ref-type="bibr" rid="bibr6-1352458511431072">6</xref></sup> on conventional imaging.</p>
<p>Several authors have used advanced magnetic resonance imaging (MRI) techniques to investigate whether patients with NMO show the occult damage in normal-appearing brain tissue (NABT)<sup><xref ref-type="bibr" rid="bibr7-1352458511431072">7</xref>-<xref ref-type="bibr" rid="bibr11-1352458511431072">11</xref></sup> that is observed in MS. The first study, using magnetization transfer imaging (MTI),<sup><xref ref-type="bibr" rid="bibr7-1352458511431072">7</xref></sup> did not find any occult damage in the NABT of eight patients with recurrent NMO (RNMO); more recently, MTI and diffusion tensor imaging (DTI) performed in 10 patients with NMO detected reduced magnetization transfer ratios (MTRs) and increased mean diffusivity (MD) values for normal-appearing grey matter (NAGM), but not for normal-appearing white matter (NAWM).<sup><xref ref-type="bibr" rid="bibr8-1352458511431072">8</xref></sup> Yu et al.,<sup><xref ref-type="bibr" rid="bibr9-1352458511431072">9</xref></sup> using DTI in 16 patients with RNMO, found global damage in the brain tissue (both NAWM and NAGM) of these patients. Moreover, after manually selecting, a priori, specific WM areas connected with the spinal tracts or optic nerve and some GM areas representative of each single lobe, abnormalities were found that could be partially explained by secondary degeneration. Neither of the two MR spectroscopy (<sup><xref ref-type="bibr" rid="bibr1-1352458511431072">1</xref></sup>H-MRS) studies present in the literature, performed with different magnets (1.5 vs. 3 T) and using different techniques (single vs. multivoxel), reported metabolic changes in NMO brain tissue.<sup><xref ref-type="bibr" rid="bibr10-1352458511431072">10</xref>,<xref ref-type="bibr" rid="bibr11-1352458511431072">11</xref></sup></p>
<p>To date, the literature contains no data derived from the combined use of several advanced MRI techniques in the same NMO subjects. In view of this, we set out to determine whether occult damage could be detected in the NABT of a small group of patients with NMO, using a multiparametric MRI approach. The techniques used were MTI, DTI, tract-based spatial statistics (TBSS), <sup><xref ref-type="bibr" rid="bibr1-1352458511431072">1</xref></sup>H-MRS and voxel-based morphometry (VBM).</p>
</sec>
<sec id="section2-1352458511431072" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-1352458511431072">
<title>Patients</title>
<p>Seven female patients affected by clinically definite NMO, diagnosed according to the Wingerchuck criteria,<sup><xref ref-type="bibr" rid="bibr2-1352458511431072">2</xref></sup> and one with a single episode of ON associated with NMO-IgG positivity (considered an NMO spectrum disorder) were included in this study (<xref ref-type="table" rid="table1-1352458511431072">Table 1</xref>). Seven sex- and age-matched healthy individuals (<italic>t</italic>-test, <italic>p</italic> = 0.27) were recruited as the control group (HCs). A local ethical committee approved this prospective study and all subjects gave their written consent.</p>
<table-wrap id="table1-1352458511431072" position="float">
<label>Table 1.</label>
<caption><p>Diagnostic criteria in all the patients.</p></caption>
<graphic alternate-form-of="table1-1352458511431072" xlink:href="10.1177_1352458511431072-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Patients</th>
<th align="left">Optic neuritis</th>
<th align="left">myelitis</th>
<th align="left">Spinal cord lesion &gt; 3 segments</th>
<th align="left">Brain MRI nondiagnostic for MS</th>
<th align="left">NMO-IgG/AQP4 positivity</th>
</tr>
</thead>
<tbody>
<tr>
<td>1<xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>+/+</td>
</tr>
<tr>
<td>2<xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>−/−</td>
</tr>
<tr>
<td>3<xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>−/+</td>
</tr>
<tr>
<td>4<xref ref-type="table-fn" rid="table-fn1-1352458511431072">*</xref><xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td/>
<td>X</td>
<td>X</td>
<td>X</td>
<td>+/+</td>
</tr>
<tr>
<td>5<xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td>X</td>
<td/>
<td/>
<td>X</td>
<td>+/−</td>
</tr>
<tr>
<td>6<xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>+/+</td>
</tr>
<tr>
<td>7<xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>−/+</td>
</tr>
<tr>
<td>8<xref ref-type="table-fn" rid="table-fn2-1352458511431072">^</xref></td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>X</td>
<td>−/+</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1352458511431072">
<label>*</label>
<p>This patient never experienced a clinically evident optic neuritis, but visual evoked potentials showed a bilateral involvement of optic nerves</p></fn>
<fn id="table-fn2-1352458511431072">
<label>^</label>
<p>In these patients, brain magnetic resonance imaging (MRI) showed the presence of small nonspecific lesions not fulfilling diagnostic criteria for multple sclerosis (MS)</p></fn>
</table-wrap-foot>
</table-wrap>
<p>The patients had a mean age of 50 years (range 44–58), a mean age at disease onset of 36.1 years (± 10.2), and a mean disease duration of 14 years (±10.25). All the patients but one had a relapsing disease course; the remaining patient, having experienced only one episode of ON, showed a monophasic disease course. The ON in the patients with RMNO was unilateral in three cases and bilateral in one; myelitis was present in all the patients with RMNO. The number of relapses in these patients ranged from 5–25.</p>
<p>The mean interval between the onset of the disease and the execution of the advanced MRI techniques analysed in this paper was 13.25 years (range 1–32). Brain MRI was negative in all but five cases, in whom only small, bilateral, subcortical lesions with no gadolinium enhancement were found. In all the patients except the one with monophasic disease, spine MRI disclosed at least one lesion extending over three segments.</p>
<p>Disease severity was calculated using the score constructed by Wingerchuck et al.<sup><xref ref-type="bibr" rid="bibr12-1352458511431072">12</xref></sup> at two different time points: the time of maximum degree of disability for each single functional system, and the time of MRI examination. Four patients showed severe, predominantly bilateral impairment of the visual system in the acute phase of ON (the mean score of the involved eye was 5.5), while the other patients showed moderate impairment (mean score 3). At the time of MRI most patients presented a moderate-to-good recovery of visual function (mean score 1), and only one patient was found to be almost blind bilaterally.</p>
<p>The motor system at nadir in the patients with myelitis was markedly impaired in three subjects (mean score 4.5) and moderately impaired in the other four (mean score 3). All the patients achieved a partial motor recovery over time (mean score 3). The recovery of sensory and sphincteric functions showed a similar time course.</p>
<p>Cerebrospinal fluid (CSF) analysis, performed in seven cases and at least twice in the acute phase, showed only mild lymphocytic pleocytosis and hyperproteinorrachia; six of the seven RMNO patients had oligoclonal bands in the first analysis, but these disappeared over time in two cases.</p>
<p>Testing for NMO-IgG and Ab antiaqp4 was performed in all patients. Both investigations were both positive in three patients and negative in one; three cases were NMO-IgG negative and Ab antiaqp4 positive, while the last case was MO-IgG positive and Ab antiaqp4 negative.</p>
</sec>
<sec id="section4-1352458511431072">
<title>MR imaging and MR spectroscopy</title>
<p>MR images of the brain were obtained using an eight-channel 1.5 T MRI scanner (Philips Gyroscan, Koninklijke, The Netherlands). An eight-channel head (SENSE) third-party coil was used to acquire the following sequences: 1) axial 3D high resolution (HIRES) T1-WI using a fast gradient echo (fast field echo, FFE) (TR = 25 ms, TE = 4.6 ms, slice thickness = 1.6 mm, voxel dimension = 0.97 mm, FOV = 250 mm, reconstruction matrix = 256 × 256, number of slices = 160); 2) axial DP-T2 spin echo (SE) sequence (TR = 25 ms, TE = 4.6 ms, slice thickness = 1.6 mm, voxel dimension = 0.97 mm, FOV = 250 mm, reconstruction matrix = 256 × 256, number of slices = 160); 3) axial DTI pulse gradient spin echo (PGSE) echo planar pulse sequence (TR = 9.17 s, TE = 68 ms, b-values: 0–800 s/mm<sup>2</sup>, slice thickness = 2.33 mm, gap = 0 mm, voxel dimension = 2 mm, FOV = 224 mm, reconstruction matrix = 112 × 112, number of slices = 55, number of averages = 3), with a total of 16 images acquired, 15 with noncollinear diffusion weighting gradients with a b-value of 800 s/mm<sup>2</sup> and one without diffusion weighting; 4) 2D FFE T1-WI using FFE with and without an off-resonance radiofrequency saturation pulse (MTI, offset frequency = 1.5 kHz, TR/TE = 650/10, flip angle = 30°, 22 axial 3 mm-thick slices, matrix = 256 × 192, FOV = 250 × 188).</p>
<p><sup>1</sup>H-MRS was performed to assess the metabolic pattern in the NAWM. Measurements were performed parallel to axial T1- and T2-weighted sections, with routine automatic adjustments applied before data acquisition. A rectangular voxel of interest (13 × 11 × 2 cm) was selected in the frontoparietal WM well above the lateral ventricles; special care was taken to avoid skull and subcutaneous tissue contamination. Chemical shift imaging, using a 90 Hz chemical shift selective pulse for water suppression, was performed with the following parameters: TE = 288 ms, TM interval = 30 ms; TR = 2000 ms; acquisition matrix = 192 × 192; data size = 1024; spectrum amplitude = 1000 Hz; NA = 3, FOV = 180 mm, Lorentzian filter. To obtain an internal quantification reference, additional scanning was performed with the same timing and geometric parameters but without water suppression. The total acquisition time of the spectroscopic sequences was &lt; 15 min.</p>
</sec>
<sec id="section5-1352458511431072">
<title>Post-analysis</title>
<p>Image analysis was performed on an off-line workstation by four operators (GP, FP and MP, with 5 years of experience in MRI post-analysis, and DT, with 3 years’ experience in brain lesion measurements).</p>
<sec id="section6-1352458511431072">
<title>Lesion measurements</title>
<p>Brain lesions, when present, were identified on DP-T2-weighted images and masked using a semi-automated edge-detection contouring-threshold technique implemented in the Jim image analysis package, Version 5.0 (Xinapse Systems Ltd., Northants, UK, <ext-link ext-link-type="uri" xlink:href="http://www.xinapse.com">www.xinapse.com</ext-link>).</p>
</sec>
<sec id="section7-1352458511431072">
<title>Brain tissue segmentation</title>
<p>GM, WM and CSF were segmented with the FAST automated algorithm<sup><xref ref-type="bibr" rid="bibr13-1352458511431072">13</xref></sup> from the 3D HIRES T1-WI, after the N3 non-parametric signal uniformity correction<sup><xref ref-type="bibr" rid="bibr14-1352458511431072">14</xref>,<xref ref-type="bibr" rid="bibr15-1352458511431072">15</xref></sup> and the lesion regions of interest (ROIs) masking.</p>
</sec>
<sec id="section8-1352458511431072">
<title>Magnetic transfer tissue-specific histogram analysis</title>
<p>MTR maps were calculated on as: MTR(%) = (M0 - Mmt)/M0,<sup><xref ref-type="bibr" rid="bibr16-1352458511431072">16</xref></sup> M0 and Mmt being the 2D FFE T1-WI sequences with and without off-resonance MT saturation pulse, respectively. Histograms for NABT and NAGM and NAWM were produced. For each histogram, the average MTR, peak height, peak position and full width at half height (FWHH) were calculated.</p>
</sec>
<sec id="section9-1352458511431072">
<title>MD and fractional anisotropy histogram analysis</title>
<p>DTI data were processed using the FDT FMRIB Software Library (FSL, <ext-link ext-link-type="uri" xlink:href="http://www.fmrib.ox.ac.uk/fsl">http://www.fmrib.ox.ac.uk/fsl</ext-link>).<sup><xref ref-type="bibr" rid="bibr17-1352458511431072">17</xref></sup> A correction for motion and Eddy current distortions was applied, prior to the reconstruction of the MD and fractional anisotropy (FA) maps.<sup><xref ref-type="bibr" rid="bibr18-1352458511431072">18</xref></sup> Histograms for NABT, NAGM and NAWM were produced for the MD and FA maps and average MD and FA, peak height, peak position and full width at half maximum (FWHM) were calculated.</p>
</sec>
<sec id="section10-1352458511431072">
<title>TBSS</title>
<p>The TBSS algorithm allows for a track specific DTI processing, able therefore to control for global and partial volume related effects. The TBSS pipeline was run along the following steps:<sup><xref ref-type="bibr" rid="bibr19-1352458511431072">19</xref></sup> 1) masking of all lesions identified on the anatomical images with a missing value tag (Not-a-Number, NaN) in the MD and FA maps; 2) non-linear registration of all FA maps to the subject closest to the group mean, in order to minimize the warping required; 3) affine transformation onto the standard MNI space; 4) generation and thresholding of the mean FA map to obtain a binary skeleton mask identifying the voxels to be used in all subsequent processing. The final voxelwise analysis was performed using FSL’s randomize program,<sup><xref ref-type="bibr" rid="bibr20-1352458511431072">20</xref></sup> choosing the threshold-free cluster enhancement (TFCE) option,<sup><xref ref-type="bibr" rid="bibr21-1352458511431072">21</xref></sup> which combines general linear model (GLM) testing with permutation inference statistics.</p>
</sec>
<sec id="section11-1352458511431072">
<title>VBM</title>
<p>HIRES data were analysed using the SPM5 (Wellcome Department of Cognitive Neurology, <ext-link ext-link-type="uri" xlink:href="http://www.fil.ion.ucl.ac.uk">www.fil.ion.ucl.ac.uk</ext-link>) toolbox for MATLAB 7.9 (The MathWorks, Natick, MA, USA). VBM processing was performed as described by Good et al.,<sup><xref ref-type="bibr" rid="bibr22-1352458511431072">22</xref></sup> along the following steps: 1) extraction of the brain parenchyma and segmentation in GM and WM; 2) normalization of GM/WM maps onto the MNI template; 3) multiplication (modulation) of the voxel intensities in the GM/WM maps by the determinant of the Jacobian derived from the spatial normalization step: modulated data provide regional differences in the absolute amount (volume) of GM/WM, whereas non-modulated data correspond to differences in concentration of GM/WM (per unit volume in native space);<sup><xref ref-type="bibr" rid="bibr23-1352458511431072">23</xref></sup> 4) each normalized, segmented, modulated image is smoothed with an 8 mm FWHM Gaussian kernel. The voxelwise statistics on the resulting maps was performed applying a GLM<sup><xref ref-type="bibr" rid="bibr24-1352458511431072">24</xref></sup> and including age as nuisance variable for GM and WM comparisons. The resulting <italic>t</italic>-statistic maps, corrected for multiple comparisons using family-wise error correction, were thresholded at a <italic>p</italic> &lt; 0.05.</p>
</sec>
<sec id="section12-1352458511431072">
<title><sup>1</sup>H-MRS analysis</title>
<p>Quantification of the spectra was performed off-line in the time domain using the jMRUI software package.<sup><xref ref-type="bibr" rid="bibr25-1352458511431072">25</xref></sup> Signals from frontal and parietal WM voxels matching previous masking of lesion load were selected. Choline (Cho), creatine (Cr), and N-acetil-aspartate (NAA) signals were quantified by means of the advanced method for accurate, robust, and efficient spectral fitting (AMARES)<sup><xref ref-type="bibr" rid="bibr26-1352458511431072">26</xref></sup> using prior knowledge basis functions. The residue water signal was removed using a Hankel–Lanczos singular value decomposition filter prior to the quantification. Metabolite ratios with respect to Cr were calculated.</p>
</sec>
</sec>
<sec id="section13-1352458511431072">
<title>Statistical analysis</title>
<p>The Student <italic>t</italic>-test for non-paired data was used to compare both MD, FA and MT histogram-derived measurements and metabolite ratios (NAA/Cr and Cho/Cr) between patients with NMO and HCs. Moreover, to adjust for multiple comparisons and to avoid type II errors, the significance level was set at <italic>p</italic> ≤ 0.01 for each test. Analyses were performed by using Stata version 10 (Stata Corp, College Station, TX, USA).</p>
</sec>
</sec>
<sec id="section14-1352458511431072" sec-type="results">
<title>Results</title>
<sec id="section15-1352458511431072">
<title>DTI analysis</title>
<p>The comparison of MD histogram-derived measurements (average MD, peak height, peak position and FWHH for NABT, NAWM and NAGM) showed no statistically significant differences between NMO patients and HCs. Comparison of the FA histogram-derived measurements confirmed this result for NABT and NAWM; instead, the NAGM average FA value was found to differ significantly between the NMO patients and the HCs (0.16 ± 0.01 vs. 0.14 ± 0.01, <italic>p</italic> = 0.002) as well as the mean peak height (67.15 ± 7.28 vs. 79.48 ± 4.72, <italic>p</italic> = 0.002) (<xref ref-type="table" rid="table2-1352458511431072">Table 2</xref>).</p>
<table-wrap id="table2-1352458511431072" position="float">
<label>Table 2.</label>
<caption><p>Mean diffusivity, fractional anisotropy and magnetization transfer ratio histogram-derived measures of normal-appearing brain tissue, normal-appearing white matter and normal-appearing grey matter for patients with neuromyelitis optica and healthy controls.</p></caption>
<graphic alternate-form-of="table2-1352458511431072" xlink:href="10.1177_1352458511431072-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">HCs <italic>n</italic>=7</th>
<th align="left">NMO <italic>n</italic>=8</th>
<th align="left"><xref ref-type="table-fn" rid="table-fn3-1352458511431072">*</xref><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="4"><bold>NABT</bold></td>
</tr>
<tr>
<td>average MD (SD) × 10<sup>−3</sup> mm<sup>2</sup>/s</td>
<td>0.91 (0.03)</td>
<td>0.93 (0.03)</td>
<td>0.329</td>
</tr>
<tr>
<td>mean MD peak height (SD) [‰]</td>
<td>32.40 (2.14)</td>
<td>31.38 (1.85)</td>
<td>0.338</td>
</tr>
<tr>
<td>average FA (SD)</td>
<td>0.22 (0.01)</td>
<td>0.22 (0.01)</td>
<td>0.220</td>
</tr>
<tr>
<td>mean FA peak height (SD) [‰]</td>
<td>37.01 (1.61)</td>
<td>37.91 (2.28)</td>
<td>0.405</td>
</tr>
<tr>
<td>average MTR (SD) [%]</td>
<td>43.18 (0.25)</td>
<td>43.25 (1.17)</td>
<td>0.879</td>
</tr>
<tr>
<td>mean MTR peak height (SD) [‰]</td>
<td>32.78 (3.78)</td>
<td>34.03 (4.42)</td>
<td>0.591</td>
</tr>
<tr>
<td colspan="4"><bold>NAWM</bold></td>
</tr>
<tr>
<td>average MD (SD) × 10<sup>−3</sup> mm<sup>2</sup>/s</td>
<td>0.80 (0.02)</td>
<td>0.82 (0.04)</td>
<td>0.227</td>
</tr>
<tr>
<td>mean MD peak height (SD) [‰]</td>
<td>50.52 (2.58)</td>
<td>46.85 (6.07)</td>
<td>0.158</td>
</tr>
<tr>
<td>average FA (SD)</td>
<td>0.33 (0.02)</td>
<td>0.31 (0.03)</td>
<td>0.117</td>
</tr>
<tr>
<td>mean FA peak height (SD) [‰]</td>
<td>32.27 (1.63)</td>
<td>32.19 (1.54)</td>
<td>0.925</td>
</tr>
<tr>
<td>average MTR (SD) [%]</td>
<td>44.21 (0.40)</td>
<td>44.30 (1.09)</td>
<td>0.854</td>
</tr>
<tr>
<td>mean MTR peak height (SD) [‰]</td>
<td>41.00 (5.24)</td>
<td>44.24 (6.02)</td>
<td>0.314</td>
</tr>
<tr>
<td colspan="4"><bold>NAGM</bold></td>
</tr>
<tr>
<td>average MD (SD) × 10<sup>−3</sup> mm<sup>2</sup>/s</td>
<td>0.96 (0.03)</td>
<td>0.99 (0.05)</td>
<td>0.246</td>
</tr>
<tr>
<td>mean MD peak height (SD) [‰]</td>
<td>28.73 (3.27)</td>
<td>25.66 (3.41)</td>
<td>0.099</td>
</tr>
<tr>
<td>average FA (SD)</td>
<td>0.14 (0.01)</td>
<td>0.16 (0.01)</td>
<td><bold><italic>0.002</italic></bold></td>
</tr>
<tr>
<td>mean FA peak height (SD) [‰]</td>
<td>79.48 (4.72)</td>
<td>67.15 (7.28)</td>
<td><bold><italic>0.002</italic></bold></td>
</tr>
<tr>
<td>average MTR (SD) [%]</td>
<td>41.16 (0.37)</td>
<td>41.18 (1.30)</td>
<td>0.971</td>
</tr>
<tr>
<td>mean MTR peak height (SD) [‰]</td>
<td>28.28 (3.21)</td>
<td>28.30 (2.65)</td>
<td>0.992</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1352458511431072">
<p>Student <italic>t</italic>-test was used to compare mean diffusivity (MD), fractional anisotropy (FA) and magnetization transfer ratio (MTR) histogram-derived measures.</p></fn>
<fn id="table-fn4-1352458511431072">
<p>SD, standard deviation; [‰], value is multiplied by 10<sup>3</sup>; NABT, normal-appearing brain tissue;</p></fn>
</table-wrap-foot>
</table-wrap>
<p>TBSS analysis showed a significantly lowered FA (<italic>p</italic> &lt; 0.05) along the pathway of the optic radiation bilaterally (<xref ref-type="fig" rid="fig1-1352458511431072">Figure 1A</xref>), also involving the lateral geniculate nuclei (<xref ref-type="fig" rid="fig1-1352458511431072">Figure 1B</xref>). Apart from the presence of significant clusters of locally reduced FA in the WM of the right superior temporal gyrus (<xref ref-type="fig" rid="fig1-1352458511431072">Figure 1A</xref>), no other pathway seemed to be involved. All significances are lost if results are corrected for multiple comparisons, almost certainly due to the relatively small subject population.</p>
<fig id="fig1-1352458511431072" position="float">
<label>Figure 1.</label>
<caption><p>Voxel-wise diffusion tensor imaging analysis showing a significantly lowered fractional anisotropy (FA) along the pathway of the optic radiation bilaterally (A) and involvement of both lateral geniculate nuclei (B).</p></caption>
<graphic xlink:href="10.1177_1352458511431072-fig1.tif"/>
</fig>
</sec>
<sec id="section16-1352458511431072">
<title>VBM analysis</title>
<p>GM analysis showed a significant reduction of both density and volume in the patients with NMO compared with the HCs, predominantly in the motor (<xref ref-type="fig" rid="fig2-1352458511431072">Figure 2A</xref>) and visual (<xref ref-type="fig" rid="fig2-1352458511431072">Figure 2B</xref>) cortex, and in regions associated with executive and language functions. In detail, bilateral involvement of the GM was found to correspond to Brodmann areas 4, 6, 8, 9, 10, 17, 18, 21, and 40. No change was observed in the WM instead. These results are summarized in <xref ref-type="table" rid="table3-1352458511431072">Table 3</xref>.</p>
<fig id="fig2-1352458511431072" position="float">
<label>Figure 2.</label>
<caption><p>Voxel-based morphometry (VBM) analysis: both density and volume reduction in the patients with neuromyelitis optica compared with the healthy controls, predominantly in the motor (A) and visual (B) areas are displayed in the axial and sagittal view, overlayed on the standard ch2 template.</p></caption>
<graphic xlink:href="10.1177_1352458511431072-fig2.tif"/>
</fig>
<table-wrap id="table3-1352458511431072" position="float">
<label>Table 3A.</label>
<caption><p>Increased concentration (modulated) differences for healthy controls relative to patients with neuromyelitis optica.</p></caption>
<graphic alternate-form-of="table3-1352458511431072" xlink:href="10.1177_1352458511431072-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Anatomical region</th>
<th align="left">Brodmann area</th>
<th align="left">Laterality</th>
<th align="left"><italic>x</italic></th>
<th align="left"><italic>y</italic></th>
<th align="left"><italic>z</italic></th>
<th align="left"><italic>Z</italic>-score</th>
<th align="left">Cluster size</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Grey matter</bold></td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>4</td>
<td>L</td>
<td>−50</td>
<td>−5</td>
<td>49</td>
<td>3.24</td>
<td>85</td>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>4</td>
<td>R</td>
<td>48</td>
<td>−9</td>
<td>51</td>
<td>2.83</td>
<td>102</td>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>6</td>
<td>L</td>
<td>−51</td>
<td>5</td>
<td>49</td>
<td>2.66</td>
<td>135</td>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>6</td>
<td>R</td>
<td>42</td>
<td>−2</td>
<td>55</td>
<td>4</td>
<td>221</td>
</tr>
<tr>
<td>Medial frontal gyrus</td>
<td>8</td>
<td>L</td>
<td>−7</td>
<td>35</td>
<td>43</td>
<td>4.44</td>
<td>78</td>
</tr>
<tr>
<td>Middle frontal gyrus</td>
<td>9</td>
<td>L</td>
<td>−46</td>
<td>36</td>
<td>30</td>
<td>3.65</td>
<td>138</td>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>9</td>
<td>R</td>
<td>49</td>
<td>30</td>
<td>34</td>
<td>3.57</td>
<td>111</td>
</tr>
<tr>
<td>Medial frontal gyrus</td>
<td>10</td>
<td>R</td>
<td>5</td>
<td>66</td>
<td>−1</td>
<td>3.36</td>
<td>110</td>
</tr>
<tr>
<td>Inferior occipital gyrus</td>
<td>17</td>
<td>L</td>
<td>−10</td>
<td>−95</td>
<td>−8</td>
<td>2.65</td>
<td>58</td>
</tr>
<tr>
<td>Lingual gyrus</td>
<td>17</td>
<td>R</td>
<td>7</td>
<td>−96</td>
<td>−3</td>
<td>2.85</td>
<td>69</td>
</tr>
<tr>
<td>Cuneus</td>
<td>18</td>
<td>L</td>
<td>−10</td>
<td>−92</td>
<td>24</td>
<td>3.73</td>
<td>68</td>
</tr>
<tr>
<td>Cuneus</td>
<td>18</td>
<td>R</td>
<td>5</td>
<td>−94</td>
<td>27</td>
<td>4.1</td>
<td>191</td>
</tr>
<tr>
<td>Middle temporal gyrus</td>
<td>21</td>
<td>L</td>
<td>−50</td>
<td>9</td>
<td>−36</td>
<td>3.7</td>
<td>55</td>
</tr>
<tr>
<td>Middle temporal gyrus</td>
<td>21</td>
<td>R</td>
<td>50</td>
<td>6</td>
<td>−31</td>
<td>3.16</td>
<td>71</td>
</tr>
<tr>
<td>Inferior parietal lobule</td>
<td>40</td>
<td>L</td>
<td>−46</td>
<td>−32</td>
<td>40</td>
<td>2.72</td>
<td>50</td>
</tr>
<tr>
<td>Inferior parietal lobule</td>
<td>40</td>
<td>R</td>
<td>68</td>
<td>−34</td>
<td>37</td>
<td>3.25</td>
<td>52</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="table4-1352458511431072" position="float">
<label>Table 3B.</label>
<caption><p>Increased volume (unmodulated) differences for helathy controls relative to patients with neuromyelitis optica.</p></caption>
<graphic alternate-form-of="table4-1352458511431072" xlink:href="10.1177_1352458511431072-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Anatomical region</th>
<th align="left">Brodmann area</th>
<th align="left">Laterality</th>
<th align="left"><italic>x</italic></th>
<th align="left"><italic>y</italic></th>
<th align="left"><italic>z</italic></th>
<th align="left"><italic>Z</italic>-score</th>
<th align="left">Cluster size</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Grey matter</bold></td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>4</td>
<td>L</td>
<td>−50</td>
<td>−3</td>
<td>49</td>
<td>2.88</td>
<td>127</td>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>4</td>
<td>R</td>
<td>51</td>
<td>−6</td>
<td>51</td>
<td>3.05</td>
<td>152</td>
</tr>
<tr>
<td>Middle frontal gyrus</td>
<td>6</td>
<td>L</td>
<td>−39</td>
<td>2</td>
<td>52</td>
<td>3.69</td>
<td>161</td>
</tr>
<tr>
<td>Precentral gyrus</td>
<td>6</td>
<td>R</td>
<td>46</td>
<td>−2</td>
<td>51</td>
<td>3.05</td>
<td>122</td>
</tr>
<tr>
<td>Medial frontal gyrus</td>
<td>8</td>
<td>L</td>
<td>−3</td>
<td>28</td>
<td>47</td>
<td>3.03</td>
<td>63</td>
</tr>
<tr>
<td>Middle frontal gyrus</td>
<td>9</td>
<td>L</td>
<td>−44</td>
<td>36</td>
<td>28</td>
<td>3.89</td>
<td>142</td>
</tr>
<tr>
<td>Middle frontal gyrus</td>
<td>9</td>
<td>R</td>
<td>47</td>
<td>31</td>
<td>31</td>
<td>3.92</td>
<td>178</td>
</tr>
<tr>
<td>Medial frontal gyrus</td>
<td>10</td>
<td>R</td>
<td>7</td>
<td>69</td>
<td>−3</td>
<td>3.29</td>
<td>123</td>
</tr>
<tr>
<td>Inferior occipital gyrus</td>
<td>17</td>
<td>L</td>
<td>−24</td>
<td>−101</td>
<td>−4</td>
<td>2.64</td>
<td>54</td>
</tr>
<tr>
<td>Lingual gyrus</td>
<td>17</td>
<td>R</td>
<td>6</td>
<td>−95</td>
<td>−2</td>
<td>3.15</td>
<td>72</td>
</tr>
<tr>
<td>Cuneus</td>
<td>18</td>
<td>L</td>
<td>−7</td>
<td>−88</td>
<td>29</td>
<td>3.57</td>
<td>76</td>
</tr>
<tr>
<td>Cuneus</td>
<td>18</td>
<td>R</td>
<td>5</td>
<td>−94</td>
<td>26</td>
<td>4.56</td>
<td>189</td>
</tr>
<tr>
<td>Middle temporal gyrus</td>
<td>21</td>
<td>L</td>
<td>−49</td>
<td>0</td>
<td>−39</td>
<td>4.55</td>
<td>78</td>
</tr>
<tr>
<td>Middle temporal gyrus</td>
<td>21</td>
<td>R</td>
<td>57</td>
<td>8</td>
<td>−28</td>
<td>3.17</td>
<td>105</td>
</tr>
<tr>
<td>Inferior parietal lobule</td>
<td>40</td>
<td>L</td>
<td>−47</td>
<td>−32</td>
<td>38</td>
<td>3.7</td>
<td>81</td>
</tr>
<tr>
<td>Inferior parietal lobule</td>
<td>40</td>
<td>R</td>
<td>57</td>
<td>−32</td>
<td>47</td>
<td>2.38</td>
<td>56</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section17-1352458511431072">
<title><sup>1</sup>H-MRS analysis</title>
<p>As shown in <xref ref-type="fig" rid="fig3-1352458511431072">Figure 3</xref>, between-group comparisons of the NAA/Cr and Cho/Cr ratios did not reveal any significant difference, when considering either total NAWM or frontal and parietal NAWM.</p>
<fig id="fig3-1352458511431072" position="float">
<label>Figure 3.</label>
<caption><p><sup>1</sup>H-MRS ratios of brain Choline (Cho)/Creatine (Cr) and N-acetyl-aspartate (NAA)/Cr metabolites in the normal-appearing white matter of healthy controls (HCs) and patients with neuromyelitis optica (NMO).</p>
<p>Horizontal hatching bars indicate means.</p></caption>
<graphic xlink:href="10.1177_1352458511431072-fig3.tif"/>
</fig>
</sec>
<sec id="section18-1352458511431072">
<title>MTI analysis</title>
<p>Analysis of MTR in the cortical and deep GM and WM did not reveal differences between the patients with NMO and the HCs (<xref ref-type="table" rid="table2-1352458511431072">Table 2</xref>).</p>
</sec>
</sec>
<sec id="section19-1352458511431072" sec-type="discussion">
<title>Discussion</title>
<p>Traditionally, NMO was considered part of the MS spectrum even though the selective involvement of the optic nerve and spine with sparing of the brain argued against this interpretation. However, the identification of a humoral marker specific to NMO, namely Ab antiaqp4,<sup><xref ref-type="bibr" rid="bibr3-1352458511431072">3</xref></sup> has now put an end to this debate. A few reports of brain lesions in patients with NMO,<sup><xref ref-type="bibr" rid="bibr4-1352458511431072">4</xref>-<xref ref-type="bibr" rid="bibr6-1352458511431072">6</xref></sup> not corresponding to the MS diagnostic criteria, led some authors to hypothesize that there could also be occult damage in the NABT of patients with NMO.<sup><xref ref-type="bibr" rid="bibr7-1352458511431072">7</xref>-<xref ref-type="bibr" rid="bibr11-1352458511431072">11</xref></sup> In an attempt to shed light on this issue, we examined the NABT of patients with NMO using a combination of advanced MRI techniques.</p>
<p>In accordance with the findings of other authors,<sup><xref ref-type="bibr" rid="bibr8-1352458511431072">8</xref></sup> our analysis of the NAWM showed no differences in MD, FA, MTR and VBM between NMO patients and HCs; conversely, Yu et al.<sup><xref ref-type="bibr" rid="bibr9-1352458511431072">9</xref></sup> found higher MD and FA values in NMO, even though the differences between absolute values were extremely subtle, as the authors themselves pointed out. Voxelwise analysis of FA in our study demonstrated a selective, bilateral alteration of the optic pathways also involving the lateral geniculate nuclei. This finding might suggest anterograde degeneration secondary to an optic nerve lesion not detectable on conventional MRI,<sup><xref ref-type="bibr" rid="bibr27-1352458511431072">27</xref></sup> despite the investigation of the correlation between FA and visual function that would be necessary for supporting this interpretation. On the other hand, the explanation for the apparent sparing of all the other pathways, including the pyramidal functional system, which was impaired in all the patients, may lie in a technical limitation of TBSS, which is relatively less sensitive in the feet-to-head as opposed to the axial direction, which corresponds to the acquisition plain for the DTI–EPI sequence.</p>
<p>In our study, MD and FA in the NAGM were found to be slightly, but significantly, different in the patients with NMO versus the HCs. This finding agrees with the results of previous studies.<sup><xref ref-type="bibr" rid="bibr8-1352458511431072">8</xref>,<xref ref-type="bibr" rid="bibr9-1352458511431072">9</xref></sup> Specifically, Rocca et al.<sup><xref ref-type="bibr" rid="bibr8-1352458511431072">8</xref></sup> demonstrated global GM involvement, while Yu et al.,<sup><xref ref-type="bibr" rid="bibr9-1352458511431072">9</xref></sup> by means of manual ROI analysis, also demonstrated focal parietal GM damage. The results of our VBM analysis demonstrated a significant density and volume reduction of the sensorimotor cortex and the visual cortex, consistent with the hypotheses, respectively, of retrograde and anterograde degeneration of the specific pathways deriving from the macroscopically damaged spine and optic nerve. Another interesting finding was the involvement of the frontotemporal circuits connected with language and executive functions, which was consistent with the specific patterns seen in cognitive disorders recently reported in NMO.<sup><xref ref-type="bibr" rid="bibr28-1352458511431072">28</xref></sup></p>
<p>As for structural information, <sup><xref ref-type="bibr" rid="bibr1-1352458511431072">1</xref></sup>H-MRS showed that there are no metabolic changes in the NAWM in patients with NMO, confirming previous results by Bichuetti et al.<sup><xref ref-type="bibr" rid="bibr10-1352458511431072">10</xref></sup> and Aboul-Enein et al.<sup><xref ref-type="bibr" rid="bibr11-1352458511431072">11</xref></sup> Our data were obtained using the same multivoxel technique used in the more recent study,<sup><xref ref-type="bibr" rid="bibr11-1352458511431072">11</xref></sup> but on a 1.5 T magnet. Taken together, the results obtained in these three small cohorts seem to support the hypothesis that NMO is characterized by the absence of an occult diffuse degenerative process in the NAWM, strengthening the concept that NMO and MS are different pathological entities. Future applications of <sup><xref ref-type="bibr" rid="bibr1-1352458511431072">1</xref></sup>H-MRS on specific WM tracts, such as optic pathways, and GM regions, may confirm the presence of selective brain structure involvement, as indicated by our structural data.</p>
<p>Indeed, our results highlighted the presence of occult structural damage in the brains of patients with NMO: we found a selective impairment of optic pathways in the WM, while the GM was predominantly involved in regions connected with motor and visual systems. This damage seems to be the direct consequence of transsynaptic degeneration triggered by lesions of the optic nerve and spine rather than an inflammatory–degenerative process of the brain per se.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></fn>
<fn fn-type="conflict">
<p>We declare that we have no conflict of interest.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458511431072">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Riordan</surname><given-names>JI</given-names></name>
<name><surname>Gallagher</surname><given-names>HL</given-names></name>
<name><surname>Thompson</surname><given-names>AJ</given-names></name>
<etal/>
</person-group>. <article-title>Clinical, CSF, and MRI findings in Devic’s neuromyelitis optica</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <year>1996</year>; <volume>60</volume>: <fpage>382</fpage>–<lpage>387</lpage>.</citation>
</ref>
<ref id="bibr2-1352458511431072">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wingerchuk</surname><given-names>DM</given-names></name>
<name><surname>Lennon</surname><given-names>VA</given-names></name>
<name><surname>Pittock</surname><given-names>SJ</given-names></name>
<name><surname>Lucchinetti</surname><given-names>CF</given-names></name>
<name><surname>Weinshenker</surname><given-names>BG</given-names></name>
</person-group>. <article-title>Revised diagnostic criteria for neuromyelitis optica</article-title>. <source>Neurology</source> <year>2006</year>; <volume>66</volume>: <fpage>1485</fpage>–<lpage>1489</lpage>.</citation>
</ref>
<ref id="bibr3-1352458511431072">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lennon</surname><given-names>VA</given-names></name>
<name><surname>Wingerchuk</surname><given-names>DM</given-names></name>
<name><surname>Kryzer</surname><given-names>TJ</given-names></name>
<etal/>
</person-group>. <article-title>A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis</article-title>. <source>Lancet</source> <year>2004</year>; <volume>364</volume>: <fpage>2104</fpage>–<lpage>2112</lpage>.</citation>
</ref>
<ref id="bibr4-1352458511431072">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pittock</surname><given-names>SJ</given-names></name>
<name><surname>Weinshenker</surname><given-names>BG</given-names></name>
<name><surname>Lucchinetti</surname><given-names>CF</given-names></name>
<name><surname>Wingerchuk</surname><given-names>DM</given-names></name>
<name><surname>Corboy</surname><given-names>JR</given-names></name>
<name><surname>Lennon</surname><given-names>VA</given-names></name>
</person-group>. <article-title>Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression</article-title>. <source>Arch Neurol</source> <year>2006</year>; <volume>63</volume>: <fpage>964</fpage>–<lpage>968</lpage>.</citation>
</ref>
<ref id="bibr5-1352458511431072">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Poppe</surname><given-names>AY</given-names></name>
<name><surname>Lapierre</surname><given-names>Y</given-names></name>
<name><surname>Melançon</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Neuromyelitis optica with hypothalamic involvement</article-title>. <source>Mult Scler</source> <year>2005</year>; <volume>11</volume>: <fpage>617</fpage>–<lpage>621</lpage>.</citation>
</ref>
<ref id="bibr6-1352458511431072">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pittock</surname><given-names>SJ</given-names></name>
<name><surname>Lennon</surname><given-names>VA</given-names></name>
<name><surname>Krecke</surname><given-names>K</given-names></name>
<name><surname>Wingerchuk</surname><given-names>DM</given-names></name>
<name><surname>Lucchinetti</surname><given-names>CF</given-names></name>
<name><surname>Weinshenker</surname><given-names>BG</given-names></name>
</person-group>. <article-title>Brain abnormalities in neuromyelitis optica</article-title>. <source>Arch Neurol</source> <year>2006</year>; <volume>63</volume>: <fpage>390</fpage>–<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr7-1352458511431072">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Filippi</surname><given-names>M</given-names></name>
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Moiola</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic’s neuromyelitis optica</article-title>. <source>Neurology</source> <year>1999</year>; <volume>53</volume>: <fpage>1705</fpage>–<lpage>1710</lpage>.</citation>
</ref>
<ref id="bibr8-1352458511431072">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Agosta</surname><given-names>F</given-names></name>
<name><surname>Mezzapesa</surname><given-names>DM</given-names></name>
<etal/>
</person-group>. <article-title>Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica</article-title>. <source>Neurology</source> <year>2004</year>; <volume>62</volume>: <fpage>476</fpage>–<lpage>478</lpage>.</citation>
</ref>
<ref id="bibr9-1352458511431072">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>CS</given-names></name>
<name><surname>Lin</surname><given-names>FC</given-names></name>
<name><surname>Li</surname><given-names>KC</given-names></name>
<etal/>
</person-group>. <article-title>Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica</article-title>. <source>AJNR Am J Neuroradiol</source> <year>2006</year>; <volume>27</volume>: <fpage>1009</fpage>–<lpage>1015</lpage>.</citation>
</ref>
<ref id="bibr10-1352458511431072">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bichuetti</surname><given-names>DB</given-names></name>
<name><surname>Rivero</surname><given-names>RL</given-names></name>
<name><surname>de Oliveira</surname><given-names>EM</given-names></name>
<etal/>
</person-group>. <article-title>White matter spectroscopy in neuromyelitis optica: a case control study</article-title>. <source>J Neurol</source> <year>2008</year>; <volume>255</volume>: <fpage>1895</fpage>–<lpage>1899</lpage>.</citation>
</ref>
<ref id="bibr11-1352458511431072">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aboul-Enein</surname><given-names>F</given-names></name>
<name><surname>Krssák</surname><given-names>M</given-names></name>
<name><surname>Höftberger</surname><given-names>R</given-names></name>
<name><surname>Prayer</surname><given-names>D</given-names></name>
<name><surname>Kristoferitsch</surname><given-names>W</given-names></name>
</person-group>. <article-title>Diffuse white matter damage is absent in neuromyelitis optica</article-title>. <source>AJNR Am J Neuroradiol</source> <year>2010</year>; <volume>31</volume>: <fpage>76</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr12-1352458511431072">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wingerchuk</surname><given-names>DM</given-names></name>
<name><surname>Hogancamp</surname><given-names>WF</given-names></name>
<name><surname>O’Brien</surname><given-names>PC</given-names></name>
<name><surname>Weinshenker</surname><given-names>BG</given-names></name>
</person-group>. <article-title>The clinical course of neuromyelitis optica (Devic’s syndrome)</article-title>. <source>Neurology</source> <year>1999</year>; <volume>53</volume>: <fpage>1107</fpage>–<lpage>1114</lpage>.</citation>
</ref>
<ref id="bibr13-1352458511431072">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Brady</surname><given-names>M</given-names></name>
<name><surname>Smith</surname><given-names>S</given-names></name>
</person-group>. <article-title>Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm</article-title>. <source>IEEE Trans Med Imaging</source> <year>2001</year>; <volume>20</volume>: <fpage>45</fpage>–<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr14-1352458511431072">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sled</surname><given-names>JG</given-names></name>
<name><surname>Zijdenbos</surname><given-names>AP</given-names></name>
<name><surname>Evans</surname><given-names>AC</given-names></name>
</person-group>. <article-title>A nonparametric method for automatic correction of intensity nonuniformity in MRI data</article-title>. <source>IEEE Trans Med Imaging</source> <year>1998</year>; <volume>17</volume>: <fpage>87</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr15-1352458511431072">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>W</given-names></name>
<name><surname>Chee</surname><given-names>MW</given-names></name>
<name><surname>Zagorodnov</surname><given-names>V</given-names></name>
</person-group>. <article-title>Improvement of brain segmentation accuracy by optimizing non-uniformity correction using N3</article-title>. <source>Neuroimage</source> <year>2009</year>; <volume>48</volume>: <fpage>73</fpage>–<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr16-1352458511431072">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Audoin</surname><given-names>B</given-names></name>
<name><surname>Ranjeva</surname><given-names>JP</given-names></name>
<name><surname>Au Duong</surname><given-names>MV</given-names></name>
<etal/>
</person-group>. <article-title>Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis</article-title>. <source>J Magn Reson Imaging</source> <year>2004</year>; <volume>20</volume>: <fpage>765</fpage>–<lpage>771</lpage>.</citation>
</ref>
<ref id="bibr17-1352458511431072">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Behrens</surname><given-names>TE</given-names></name>
<name><surname>Woolrich</surname><given-names>MW</given-names></name>
<name><surname>Jenkinson</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Characterization and propagation of uncertainty in diffusion-weighted MR imaging</article-title>. <source>Magn Reson Med</source> <year>2003</year>; <volume>50</volume>: <fpage>1077</fpage>–<lpage>1088</lpage>.</citation>
</ref>
<ref id="bibr18-1352458511431072">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Basser</surname><given-names>PJ</given-names></name>
<name><surname>Pierpaoli</surname><given-names>C</given-names></name>
</person-group>. <article-title>Microstructural features measured using diffusion tensor imaging</article-title>. <source>J Magn Reson</source> <year>1996</year>; <volume>111</volume>: <fpage>209</fpage>–<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr19-1352458511431072">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>SM</given-names></name>
<name><surname>Jenkinson</surname><given-names>M</given-names></name>
<name><surname>Johansen-Berg</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data</article-title>. <source>Neuroimage</source> <year>2006</year>; <volume>31</volume>: <fpage>1487</fpage>–<lpage>1505</lpage>.</citation>
</ref>
<ref id="bibr20-1352458511431072">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bullmore</surname><given-names>ET</given-names></name>
<name><surname>Suckling</surname><given-names>J</given-names></name>
<name><surname>Overmeyer</surname><given-names>S</given-names></name>
<name><surname>Rabe-Hesketh</surname><given-names>S</given-names></name>
<name><surname>Taylor</surname><given-names>E</given-names></name>
<name><surname>Brammer</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain</article-title>. <source>IEEE Trans Med Imaging</source> <year>1999</year>; <volume>18</volume>: <fpage>32</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr21-1352458511431072">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smith</surname><given-names>SM</given-names></name>
<name><surname>Nichols</surname><given-names>TE</given-names></name>
</person-group>. <article-title>Threshold-free cluster enhancement: addressing problems of smoothing threshold dependence and localisation in cluster inference</article-title>. <source>Neuroimage</source> <year>2009</year>; <volume>44</volume>: <fpage>83</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr22-1352458511431072">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Good</surname><given-names>CD</given-names></name>
<name><surname>Johnsrude</surname><given-names>IS</given-names></name>
<name><surname>Ashburner</surname><given-names>J</given-names></name>
<name><surname>Henson</surname><given-names>RN</given-names></name>
<name><surname>Friston</surname><given-names>KJ</given-names></name>
<name><surname>Frackowiak</surname><given-names>RS</given-names></name>
</person-group>. <article-title>A voxelbased morphometric study of ageing in 465 normal adult human brains</article-title>. <source>Neuroimage</source> <year>2001</year>; <volume>14</volume>: <fpage>21</fpage>–<lpage>36</lpage>.</citation>
</ref>
<ref id="bibr23-1352458511431072">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ashburner</surname><given-names>J</given-names></name>
<name><surname>Friston</surname><given-names>KJ</given-names></name>
</person-group>. <article-title>Voxel-based morphometry – the methods</article-title>. <source>Neuroimage</source> <year>2000</year>; <volume>11</volume>: <fpage>805</fpage>–<lpage>821</lpage>.</citation>
</ref>
<ref id="bibr24-1352458511431072">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Friston</surname><given-names>KJ</given-names></name>
<name><surname>Holmes</surname><given-names>AP</given-names></name>
<name><surname>Worsley</surname><given-names>K</given-names></name>
<name><surname>Poline</surname><given-names>JB</given-names></name>
<name><surname>Frith</surname><given-names>CD</given-names></name>
<name><surname>Frackowiak</surname><given-names>RS</given-names></name>
</person-group>. <article-title>Statistic parametric maps in functional imaging: A general linear approach</article-title>. <source>Hum Brain Mapp</source> <year>1995</year>; <volume>2</volume>: <fpage>189</fpage>–<lpage>210</lpage>.</citation>
</ref>
<ref id="bibr25-1352458511431072">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Naressi</surname><given-names>A</given-names></name>
<name><surname>Couturier</surname><given-names>C</given-names></name>
<name><surname>Devos</surname><given-names>JM</given-names></name>
<etal/>
</person-group>. <article-title>Java-based graphical user interface for the MRUI quantitation package</article-title>. <source>MAGMA</source> <year>2001</year>; <volume>12</volume>: <fpage>141</fpage>–<lpage>152</lpage>.</citation>
</ref>
<ref id="bibr26-1352458511431072">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vanhamme</surname><given-names>L</given-names></name>
<name><surname>van den Boogaart</surname><given-names>A</given-names></name>
<name><surname>Van Huffel</surname><given-names>S</given-names></name>
</person-group>. <article-title>Improved method for accurate and efficient quantification of MRS data with use of prior knowledge</article-title>. <source>J Magn Reson</source> <year>1997</year>; <volume>129</volume>: <fpage>35</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr27-1352458511431072">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beatty</surname><given-names>RM</given-names></name>
<name><surname>Sadun</surname><given-names>AA</given-names></name>
<name><surname>Smith</surname><given-names>L</given-names></name>
<name><surname>Vonsattel</surname><given-names>JP</given-names></name>
<name><surname>Richardson</surname><given-names>EP</given-names><suffix>Jr.</suffix></name>
</person-group> <article-title>Direct demonstration of transsynaptic degeneration in the human visual system: a comparison of retrograde and anterograde changes</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <year>1982</year>; <volume>45</volume>: <fpage>143</fpage>–<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr28-1352458511431072">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blanc</surname><given-names>F</given-names></name>
<name><surname>Zéphir</surname><given-names>H</given-names></name>
<name><surname>Lebrun</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Cognitive functions in neuromyelitis optica</article-title>. <source>Arch Neurol</source> <year>2008</year>; <volume>65</volume>: <fpage>84</fpage>–<lpage>88</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>